Abstract
The oral cavity is home to numerous viruses and micro-organisms recognized as having a role in various oral diseases as well as in infections in other parts of the body. Indeed, in general a microbial infection underlies or is believed to underlie the ample spectrum of oral diseases, from tooth enamel decay to periodontal lesions, from candidiasis to virus-induced oral squamous cell carcinomas, and bullous autoimmune oral disorders. This clinico-pathological context stresses the need of targeted therapies to specifically kill infectious agents in a complex environment such as the oral cavity, and explains the current interest in exploring peptide-based therapeutic approaches in oral and dental research. Here, we review the therapeutic potential of antimicrobial peptides such as LL-37, beta defensins, adrenomedullin, histatins, and of various peptides modulating gene expression and immuno-biological interaction(s) in oral diseases.
Keywords: Antimicrobial peptides, cytokeratin peptides, bacterial competence-stimulating peptides, desmoglein-3 peptide, oral infectious diseases, Pemphigus vulgaris, oral squamous cell carcinomas, adrenomedullin, histatins, Candida albicans
Current Pharmaceutical Design
Title: Peptides in Oral Diseases
Volume: 18 Issue: 6
Author(s): Alberta Lucchese, Agostino Guida, Massimo Petruzzi, Giovanni Capone, Luigi Laino and Rosario Serpico
Affiliation:
Keywords: Antimicrobial peptides, cytokeratin peptides, bacterial competence-stimulating peptides, desmoglein-3 peptide, oral infectious diseases, Pemphigus vulgaris, oral squamous cell carcinomas, adrenomedullin, histatins, Candida albicans
Abstract: The oral cavity is home to numerous viruses and micro-organisms recognized as having a role in various oral diseases as well as in infections in other parts of the body. Indeed, in general a microbial infection underlies or is believed to underlie the ample spectrum of oral diseases, from tooth enamel decay to periodontal lesions, from candidiasis to virus-induced oral squamous cell carcinomas, and bullous autoimmune oral disorders. This clinico-pathological context stresses the need of targeted therapies to specifically kill infectious agents in a complex environment such as the oral cavity, and explains the current interest in exploring peptide-based therapeutic approaches in oral and dental research. Here, we review the therapeutic potential of antimicrobial peptides such as LL-37, beta defensins, adrenomedullin, histatins, and of various peptides modulating gene expression and immuno-biological interaction(s) in oral diseases.
Export Options
About this article
Cite this article as:
Lucchese Alberta, Guida Agostino, Petruzzi Massimo, Capone Giovanni, Laino Luigi and Serpico Rosario, Peptides in Oral Diseases, Current Pharmaceutical Design 2012; 18 (6) . https://dx.doi.org/10.2174/138161212799277842
DOI https://dx.doi.org/10.2174/138161212799277842 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Vascular Endothelial Growth Factor: A New Paradigm for Targeting Various Diseases
Current Angiogenesis (Discontinued) Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review
Current Drug Metabolism Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Current Proteomics Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Efficacy and Safety of EGFR Inhibitors in the Treatment of EGFRPositive NSCLC Patients: A Meta-Analysis
Reviews on Recent Clinical Trials Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Profiling of Enzymatic Activities Using Peptide Arrays
Mini-Reviews in Organic Chemistry Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
Current Pharmaceutical Biotechnology Novel Insights Into c-Src
Current Pharmaceutical Design Development of Ribonucleotide Reductase Inhibitors: A Review on Structure Activity Relationships
Mini-Reviews in Medicinal Chemistry